DBT Stock Overview
Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Ben Tre Pharmaceutical Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫12,550.00 |
| 52 Week High | ₫14,700.00 |
| 52 Week Low | ₫11,000.00 |
| Beta | 0 |
| 1 Month Change | 0.40% |
| 3 Month Change | 1.62% |
| 1 Year Change | 14.09% |
| 3 Year Change | 15.04% |
| 5 Year Change | 17.85% |
| Change since IPO | 1.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| DBT | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | 1.6% | -1.3% | 1.0% |
| 1Y | 14.1% | 15.7% | 14.9% |
Return vs Industry: DBT underperformed the VN Pharmaceuticals industry which returned 15.7% over the past year.
Return vs Market: DBT matched the VN Market which returned 14.9% over the past year.
Price Volatility
| DBT volatility | |
|---|---|
| DBT Average Weekly Movement | 2.3% |
| Pharmaceuticals Industry Average Movement | 3.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in VN Market | 7.0% |
| 10% least volatile stocks in VN Market | 2.4% |
Stable Share Price: DBT has not had significant price volatility in the past 3 months.
Volatility Over Time: DBT's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1963 | n/a | n/a | www.bepharco.com |
Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, anti-inflammatory, on-site impact, and diabetics, as well as herbal medicines.
Ben Tre Pharmaceutical Joint Stock Company Fundamentals Summary
| DBT fundamental statistics | |
|---|---|
| Market cap | ₫204.88b |
| Earnings (TTM) | ₫16.89b |
| Revenue (TTM) | ₫828.64b |
0.0x
P/E Ratio0.0x
P/S RatioIs DBT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DBT income statement (TTM) | |
|---|---|
| Revenue | ₫828.64b |
| Cost of Revenue | ₫628.83b |
| Gross Profit | ₫199.81b |
| Other Expenses | ₫182.92b |
| Earnings | ₫16.89b |
Last Reported Earnings
Jun 30, 2020
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did DBT perform over the long term?
See historical performance and comparison